Halozyme Therapeutics, Inc. (HALO) is near the middle in its industry group according to InvestorsObserver. HALO gets an overall rating of 40. That means it scores higher than 40 percent of stocks. Halozyme Therapeutics, Inc. gets a 51 rank in the Biotechnology industry. Biotechnology is number 82 out of 148 industries.
HALO has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on HALO!